Literature DB >> 33670636

Platelet Activity and Its Correlation with Inflammation and Cell Count Readings in Chronic Heart Failure Patients with Reduced Ejection Fraction.

Aušra Mongirdienė1, Jolanta Laukaitienė1,2, Vilius Skipskis3, Lolita Kuršvietienė1, Julius Liobikas1,4.   

Abstract

Background and objectives: There has been an increasing interest in the role of inflammation in thrombosis complications in chronic heart failure (HF) patients. The incidence of thrombosis in HF has been shown to be the highest in patients classified as NYHA IV (New York Heart association). It is stated that inflammation is regulated by platelet-induced activation of blood leukocytes. We aimed to compare the platelet and cell count readings in chronic HF with reduced ejection fraction (HFrEF) patients according to NYHA functional class and to evaluate the correlation between those readings. Materials and methods: A total of 185 patients were examined. The results of heart echoscopy (TEE) testing; fibrinogen, N-terminal pro b-type natriuretic peptide (NT-proBNP), C reactive protein (CRP), and cortisol concentrations; complete blood counts; and a 6 min walking test were assessed and platelet aggregation was determined.
Results: Mean platelet volume (MPV) increased with deterioration of a patient's state (p < 0.005). Lymphocyte count and percentage were the lowest in the NYHA IV group (p < 0.005). Neutrophil and monocyte percentage and count were the highest (p < 0.045) in the NYHA IV group. Adenosine diphosphate (ADP)- and ADR-induced platelet aggregation was higher in the NYHA III group compared to NYHA II and I groups (p < 0.023). NYHA functional class correlated with mean platelet volume (MPV) (r = 0.311, p = 0.0001), lymphocyte count (r = -0.186, p = 0.026), monocyte count (p = 0.172, p = 0.041), and percentage (r = 0.212, p = 0.011). CRP concentration correlated with NT-proBNP (r = 0.203, p = 0.005). MPV correlated with fibrinogen concentration (r = 0.244, p = 0.004). Conclusions: (1) MPV could be considered as an additional reading reflecting a patient's condition, however the use of MPV to identify patients at risk of hypercoagulable state should be evaluated in more extensive studies; (2) increased neutrophil and monocyte counts could indicate a higher inflammatory state in chronic HFrEF.

Entities:  

Keywords:  heart failure; lymphocyte; mean platelet volume; monocyte; neutrophil; platelet; platelet aggregation

Mesh:

Substances:

Year:  2021        PMID: 33670636      PMCID: PMC7923047          DOI: 10.3390/medicina57020176

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  54 in total

1.  [Use of cephalin in coagulation tests].

Authors:  M J LARRIEU; C WEILLAND
Journal:  Rev Hematol       Date:  1957 Apr-Jun

2.  Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.

Authors:  Dirk Westermann; Diana Lindner; Mario Kasner; Christine Zietsch; K Savvatis; F Escher; J von Schlippenbach; C Skurk; Paul Steendijk; Alexander Riad; Wolfgang Poller; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circ Heart Fail       Date:  2010-11-12       Impact factor: 8.790

Review 3.  Phagocyte partnership during the onset and resolution of inflammation.

Authors:  Oliver Soehnlein; Lennart Lindbom
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

4.  Soluble CD40 ligand in acute and chronic heart failure.

Authors:  Thor Ueland; Pål Aukrust; Arne Yndestad; Kari Otterdal; Stig S Frøland; Kenneth Dickstein; John Kjekshus; Lars Gullestad; Jan K Damås
Journal:  Eur Heart J       Date:  2005-02-16       Impact factor: 29.983

Review 5.  Platelets at the interface of thrombosis, inflammation, and cancer.

Authors:  Aime T Franco; Adam Corken; Jerry Ware
Journal:  Blood       Date:  2015-06-24       Impact factor: 22.113

6.  High sensitivity C-Reactive Protein in Chronic Heart Failure: Patient Characteristics, Phenotypes and Mode of Death.

Authors:  Pierpaolo Pellicori; Jufen Zhang; Joe Cuthbert; Alessia Urbinati; Parin Shah; Syed Kazmi; Andrew L Clark; John G F Cleland
Journal:  Cardiovasc Res       Date:  2019-07-26       Impact factor: 10.787

7.  Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis.

Authors:  Henrik T Sørensen; Erzsebet Horvath-Puho; Timothy L Lash; Christian F Christiansen; Raffaele Pesavento; Lars Pedersen; John A Baron; Paolo Prandoni
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

8.  Platelet activation during angiotensin II infusion in healthy volunteers.

Authors:  P T Larsson; J H Schwieler; N H Wallén
Journal:  Blood Coagul Fibrinolysis       Date:  2000-01       Impact factor: 1.276

9.  Platelet activation in acute, decompensated congestive heart failure.

Authors:  Irene Chung; Anirban Choudhury; Gregory Y H Lip
Journal:  Thromb Res       Date:  2007-02-06       Impact factor: 3.944

10.  Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea.

Authors:  Jeong Soo Lee; Na Young Kim; Se Hee Na; Young Hoon Youn; Cheung Soo Shin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more
  2 in total

Review 1.  Phenotypic and Functional Heterogeneity of Monocyte Subsets in Chronic Heart Failure Patients.

Authors:  Aušra Mongirdienė; Julius Liobikas
Journal:  Biology (Basel)       Date:  2022-01-26

2.  Relationship Between the Eosinophil/Monocyte Ratio and Prognosis in Decompensated Heart Failure: A Retrospective Study.

Authors:  Xiehui Chen; Weichao Huang; Lingyue Zhao; Yichong Li; Lili Wang; Fanrui Mo; Wenqin Guo
Journal:  J Inflamm Res       Date:  2021-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.